Tech Company Financing Transactions
Treventis Funding Round
BioAdvance Ventures invested in a $550 thousand venture round for Treventis. The round was announced on 9/30/2009.
Transaction Overview
Company Name
Announced On
9/30/2009
Transaction Type
Venture Equity
Amount
$550,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
60 Leonard Ave. 4KD472
Toronto ON, M5T 0S8
Canada
Toronto ON, M5T 0S8
Canada
Phone
Website
Email Address
Overview
Treventis is a biotechnology company focused on diseases associated with protein misfolding such as Alzheimer's, Parkinson's and Huntington's.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christopher Barden
Chief Medical Officer
Donald Weaver
Chief Scientific Officer
Mark Reed
VP - R & D
Marcia Taylor
Browse more venture capital transactions:
Prev: 9/30/2009: RockeTalk venture capital transaction
Next: 9/30/2009: IdenTrust venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs